Ongoing tuberculosis transmission to children in Greenland

European Respiratory Journal

Volumn 36, Issue 4, 2010, Pages 878-884

  Soborg, B ^a   Koch, A ^a   Thomsen, V O ^a   Ladefoged, K ^b   Andersson, M ^a   Wohlfahrt, J ^a   Melbye, M ^a   Andersen, A B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Queen Ingrid's Hospital   (Greenland)

Author keywords

Children; Epidemiological study; Tuberculosis; Tuberculosis control

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BCG VACCINATION; CHILD; DISEASE TRANSMISSION; ETHNICITY; FEMALE; GREENLAND; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING; SEX DIFFERENCE; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; FEMALE; GREENLAND; HUMANS; INCIDENCE; INUITS; MALE; MYCOBACTERIUM TUBERCULOSIS; PUBLIC HEALTH; RISK; TUBERCULIN TEST; TUBERCULOSIS;

EID: 77957836178     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00015510     Document Type: Article

References (28)

1. Grzybowski S, Styblo K, Dorken E. Tuberculosis in Eskimos. Tubercle 1976; 57: S1-S58.
2. Stein KS. Tuberculosis in Greenland and the Fight Against It. Copenhagen, Danish National Union Against Tuberculosis and Lung Disease, 1994; pp. 7-56.
3. Soborg C, Soborg B, Pouelsen S, et al. Doubling of the tuberculosis incidence in Greenland over an 8-year period (1990-1997). Int J Tuberc Lung Dis 2001; 5: 257-265.
4. Chief Medical Officer in Greenland. Annual report from the Chief Medical Officer in Greenland. Nuuk, Chief Medical Officer in Greenland, 2007.
5. Rieder H. Annual risk of infection with Mycobacterium tuberculosis. Eur Respir J 2005; 25: 181-185.
6. Dye C, Watt CJ, Bleed DM, et al. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 2005; 293: 2767-2775.
7. Cauthen GM, Pio A, ten Dam HG. Annual risk of tuberculous infection. 1988. Bull World Health Organ 2002; 80: 503-511.
8. Kritzinger FE, den Boon S, Verver S, et al. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health 2009; 14: 136-142.
9. Arnadottir T, Rieder HL, Trebucq A, et al. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis 1996; 77: 1-19. (Pubitemid 26285466)
10. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993; 17: 968-975.
11. Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10: 1192-1204.
12. Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
13. Rothel JS, Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 2005; 3: 981-993.
14. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
15. Young K., Bjerregaard P., eds. Health Transitions in Arctic Populations. Toronto, University of Toronto Press, 2008; pp. 1-485.
16. Krause TG, Koch A, Poulsen LK, et al. Atopic sensitization among children in an arctic environment. Clin Exp Allergy 2002; 32: 367-372.
17. Pedersen CB, Gotzsche H, Moller JO, et al. The Danish Civil Registration System: a cohort of eight million persons. Dan Med Bull 2006; 53: 441-449.
18. Cellestis. www.cellestis.com. Date last updated: 2009. Date last accessed: October 2009.
19. Smeja C, Brassard P. Tuberculosis infection in an Aboriginal (First Nations) population of Canada. Int J Tuberc Lung Dis 2000; 4: 925-930.
20. Gaudette LA, Ellis E. Tuberculosis in Canada: a focal disease requiring distinct control strategies for different risk groups. Tuber Lung Dis 1993; 74: 244-253.
21. Funk EA. Tuberculosis control among Alaska Native people. Int J Tuberc Lung Dis 1998; 2: S26-S31.
22. Chee CB, Khinmar KW, Gan SH, et al. Effect of TB treatment on T-cell interferon-γ responses to M. tuberculosis-specific antigens. Eur Respir J 2010; 36: 355-361.
23. Odhiambo JA, Borgdorff MW, Kiambih FM, et al. Tuberculosis and the HIV epidemic: Increasing annual risk of tuberculous infection in Kenya, 1986-1996. Am J Public Health 1999; 89: 1078-1082.
24. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
25. Dye C, Espinal MA, Watt CJ, et al. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185: 1197-1202.
26. Basu S, Andrews JR, Poolman EM, et al. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 2007; 370: 1500-1507.
27. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-1580.
28. Rieder HL. Epidemiology of tuberculosis in Europe. Eur Respir J 1995; 8: Suppl. 20, 620s-632s.